Excitotoxicity in ALS: Overstimulation, or overreaction?

Area of Science:

• Neuroscience
• Neurology
• Cellular Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron loss.
• While 90% of ALS cases are sporadic, familial forms suggest genetic links to DNA/RNA metabolism, protein misfolding, oxidative stress, and cytoskeleton dynamics.
• Altered neuronal excitability is observed across all ALS types, suggesting a common pathogenic mechanism.

Purpose of the Study:

• To review current evidence on alterations in excitatory and inhibitory signaling in the cortex and spinal cord in ALS.
• To investigate changes in the intrinsic excitability of motor neurons in ALS.
• To explore the role of excitotoxicity and the glutamatergic system as potential therapeutic targets in ALS.

Main Methods:

• Literature review of studies investigating neuronal excitability in amyotrophic lateral sclerosis.
• Analysis of evidence regarding alterations in synaptic inputs and intrinsic neuronal properties.
• Examination of research on excitatory and inhibitory neurotransmission in ALS models and patients.

Main Results:

• Evidence suggests widespread alterations in both excitatory and inhibitory signaling pathways in the central nervous system of ALS patients.
• Changes in the intrinsic excitability of motor neurons are consistently reported across different ALS etiologies.
• Excitotoxicity, potentially mediated by glutamatergic system dysregulation, is implicated as a key factor in motor neuron degeneration.

Conclusions:

• Altered neuronal excitability represents a unifying mechanism in the pathogenesis of amyotrophic lateral sclerosis.
• Understanding the precise causes of altered excitability is critical for developing effective therapeutic strategies.
• Targeting the glutamatergic system holds promise for extending lifespan and delaying disease progression in ALS.